← Insider buys
CERE

Cerevel Therapeutics Holdings, Inc.

Chief Scientific Officer John Renger sold $750K of Cerevel Therapeutics Holdings, Inc.

Sold$750,000
$30.00Price
25,000Shares
−90%Stake

What CERE did after the filing

Prices for CERE after this filing aren't in yet.

Traded Wed, Jul 20. Filed Fri, Jul 22, 12:15 PM ET, during the session. Not investment advice.